A Systematic Review of Antiamyloidogenic and Metal-Chelating Peptoids: Two Structural Motifs for the Treatment of Alzheimer’s Disease-Reference-Cited by-同舟云学术

A Systematic Review of Antiamyloidogenic and Metal-Chelating Peptoids: Two Structural Motifs for the Treatment of Alzheimer’s Disease

Published:2018-01-31 Issue:2 Volume:23 Page:296
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Young Sherri

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/23/2/296/pdf

Reference71 articles.

1. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

2. 2017 Alzheimer's disease facts and figures

3. The Cholinergic Hypothesis of Geriatric Memory Dysfunction

4. Cholinesterase Inhibitors Used in the Treatment of Alzheimer???s Disease

5. NMDA receptor function, memory, and brain aging;Newcomer;Dialogues Clin. Neurosci.,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies employed in the design of antimicrobial peptides with enhanced proteolytic stability;Biotechnology Advances;2022-10

2. A Mini-Review on the Effectiveness of Peptoids as Therapeutic Interventions against Neurodegenerative Diseases;Current Protein & Peptide Science;2021-12-07

3. “Molecular Masks” for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry;International Journal of Molecular Sciences;2021-08-20

4. Amyloid-Targeting Drugs for the Treatment of Alzheimer Disease;Journal of the Korean Neurological Association;2021-08-01

5. Effect of antiamyloid-β drugs on Alzheimer’s disease: study protocol for a systematic review and meta-analysis;BMJ Open;2021-05